The General Clinical Research Center (GCRC) at Boston University School of Medicine is at the center of an effort to enhance clinical research at one of the best medical centers in the country in terms of clinical and basic research, clinical services and education programs targeted to the inner city. The Center is located in the new Boston Medical Center which is a full asset merger of Boston City Hospital and Boston University Medical Center Hospital. In addition, the Hospital and the Medical School have joined together with eight community health centers to form Boston HealthNet. The General Clinical Research Center supports inpatient and outpatient research services, specialized laboratories and a clinical research training program for physician scientists in Medicine, Surgery and Pediatrics. The facility provides investigators with: 1) the ability to conduct pharmacokinetic studies in a controlled environment in both adult and pediatric subjects; 2) the resources for timed collections of specimens and repetitive tests (e.g. echocardiograms, stress tests, bone density etc.); 3) the expertise to conduct esoteric laboratory testing and evaluation; 4) professionals to assist with statistical design and data analysis; 5) a private environment to explore patterns of behavior and 6) the location of education for future clinicians in patient oriented research. In conjunction with the new Office of Clinical Research at the Medical School, the Center plans to expand services to investigators including pharmacist support, state of the art PCR assays, and data management. Efforts are underway to afford inner city high school and college studies, as well as MD and MD-PhD students, an opportunity to see and learn about the exciting role clinical research plays in human health and disease. The Medical School will cost share in this expansion. The Center serves national recognized researchers focusing on the health of the inner city by studying AIDS in children and adults, hypertension in blacks, diabetes in Caribbean Latinos, hemoglobinopathies, substance abuse, angina in the elderly and maternal and child development. Bench to bedside research is being conducted in the Center on EBV-associated malignancies, nociception in newborns. Interleukin 16 in asthma, second generation active vitamin D analogues in psoriasis and immunotoxins for treating leukemia and lymphomas. In a changing health delivery system, the unique partnership of the Medical School, the Hospital and the Boston HealthNet provides a community driven urban health network that affords continued access to a patient population. The General Clinical Research Center is the place for NIH funded researchers to do bench to bedside research and physician scientists to address the full spectrum of health issues facing individuals living in the city.

National Institute of Health (NIH)
National Center for Research Resources (NCRR)
General Clinical Research Centers Program (M01)
Project #
Application #
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Program Officer
Sogn, Dorothy D
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Boston University
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Christensen, Kurt D; Uhlmann, Wendy R; Roberts, J Scott et al. (2018) A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone. Genet Med 20:132-141
Kattan, Meyer; Bacharier, Leonard B; O'Connor, George T et al. (2018) Spirometry and Impulse Oscillometry in Preschool Children: Acceptability and Relationship to Maternal Smoking in Pregnancy. J Allergy Clin Immunol Pract 6:1596-1603.e6
Rhee, Rennie L; Davis, John C; Ding, Linna et al. (2018) The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis. Clin J Am Soc Nephrol 13:251-257
Liebschutz, Jane M; Buchanan-Howland, Kathryn; Chen, Clara A et al. (2018) Childhood Trauma Questionnaire (CTQ) correlations with prospective violence assessment in a longitudinal cohort. Psychol Assess 30:841-845
Guan, Yue; Roter, Debra L; Wolff, Jennifer L et al. (2018) The impact of genetic counselors' use of facilitative strategies on cognitive and emotional processing of genetic risk disclosure for Alzheimer's disease. Patient Educ Couns 101:817-823
Altman, Matthew C; Whalen, Elizabeth; Togias, Alkis et al. (2018) Allergen-induced activation of natural killer cells represents an early-life immune response in the development of allergic asthma. J Allergy Clin Immunol 142:1856-1866
Berti, Alvise; Warner, Roscoe; Johnson, Kent et al. (2018) Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol 70:1114-1121
Wallace, Zachary S; Miloslavsky, Eli M; Cascino, Matthew et al. (2017) Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Care Res (Hoboken) 69:1004-1010
Gern, James E; Calatroni, Agustin; Jaffee, Katy F et al. (2017) Patterns of immune development in urban preschoolers with recurrent wheeze and/or atopy. J Allergy Clin Immunol 140:836-844.e7
Guan, Yue; Roter, Debra L; Erby, Lori H et al. (2017) Disclosing genetic risk of Alzheimer's disease to cognitively impaired patients and visit companions: Findings from the REVEAL Study. Patient Educ Couns 100:927-935

Showing the most recent 10 out of 476 publications